BAPTA and its derivatives are calcium chelators that are commonly used to form calcium buffers with well-defined calcium concentrations. By injecting the chelators into cells or by incubating cells with the AM ester form of the chelators, one can control the cytosolic calcium concentration, an important means to study the roles of calcium. Key advantages of these calcium chelators include relative insensitivity toward intracellular pH change and fast release of calcium.

Abbkine BAPTA, AM is a membrane permeable form of BAPTA and can be loaded into cells by incubation. BAPTA, AM does not bind calcium itself, and will not bind calcium until it is converted into BAPTA by cytoplasmic esterase after entering the cell.

More detailed information of BAPTA, AM at https://www.abbkine.com/product/bapta-am-bmd00085/.

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.